Female Lung Cancer is on the Rise in Europe, Reveals Synovate Healthcare Global Tandem Oncology Monitor
Data from the European arm of the Synovate Healthcare Global Tandem Oncology Monitor (GTOM) reveals a rise in female lung cancer across Europe’s five largest drug-treated oncology markets: the UK, France, Germany, Italy and Spain. In 2006 women now comprise almost 25% of lung cancer patients – this is up from 18% in 2001, representing a 7% growth in just five years.
This entry was posted on Thursday, November 30th, 2006 at 12:17 pm and is filed under Research, Education. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.